©_¬üÂå°|¥Í´ÞÂå¾Ç¬ì¥D¥ô ½²¥ÃªNÂå®v
¡@¡@¥Ø«e¬I¦æFL´Ó¤J«e°ò¦]¶EÂ_ªº¤Á¤ù®É¶¡¥i¤À¬°§Z¤lªº·¥Åé¤Á¤ù¡B¤ÀµõFLªºF¸¤Á¤ù(Fig.1)»PÅnF¤Á¤ù¡C¨ä¤¤¤ÀµõFLªºF¸¤Á¤ù¥i»¡¬O¹B¥Î³Ì¬°¼s¦Æªº¤@ºØ¡A¤@¯ë»¡¨Ó¬O¦bFL§¹¦¨²Ä¤T¦¸¤Àµõ«á¶i¦æ¤Á¤ù(¬ù¨üºë«á²Ä¤T¤Ñ¡BFL¤Àµõ¨ì¤»¨ì¤KÓ²ÓM®É)¡C¦Ü©óÅnF¤Á¤ù«h¥Ñ©ó¨ü©óÂ÷FL´Ó¤J®É¶¡¤Óªñ¦]¦¹¦bÁ{§Éªº¹B¥Î¤£¦h¡C Fig.1:¤K²ÓM´ÁFL¤Á¤ù ¡@¡@¤ÀªR¤èªk¡G¬I¦æFL´Ó¤J«e°ò¦]¶EÂ_¤Á¥X¨Óªº²ÓM¥i¥Î¡G1. »E¦X–¡Áå¤ÏÀ³(PCR)±N¯S²§ªº¬V¦âÅé(DNA)§Ç¦CÂX¤j¨Ó¶EÂ_³æ¤@°ò¦]¿ò¶Ç©Ê¯e¯f(monogenic disease)¡C2. ¿Ã¥úì¦ìÂø¥æ(FISH)¡GŲ©wFL²ÓMªº¡¨¬V¦âÅé®M¼Æ¡¨(ploidy)¡A¤]´N¬O¬V¦âÅé¼Æ¥Ø¡C±`°µªº¬V¦âÅ鬰13¡A15¡A16¡A17¡A18¡A21¡A22¡AX©MYªº¤ÀªR(Fig.2)¡C ¡@¡@3. ¤ñ¸û©Ê°ò¦]ì¦ìÂø¥æªk(comparative genomic hybridization¡ACGH)¡G±N¹ï·Ó²ÓMªºDNA©ñ¤j«á¬V¦¨¬õ¦â¡A¦A±N±ýÀË´ú²ÓMªºDNA©ñ¤j«á¬V¦¨ºñ¦â¡A¦Aµøºñ¦â/¬õ¦âªº¤ñ²v½u»P¼Ð·Ç¤¤¥¡½uªº°¾Â÷²v(0.75-1.25)§@¥X¬V¦âÅé¬Omonosomy(°¾¥ª¹L0.75) or trisomy(°¾¥k¹L1.25)ªº¶EÂ_8 (Fig.3)¡C
Fig.3¡GB¡GMonosomy 22¡AC¡GPartial Monosomy for 9q
¡@¡@¡C©M¿Ã¥úì¦ìÂø¥æ(FISH)¤ñ¸û°_¨Ó¨ä¦n³B¬O46±ø¬V¦âÅé³£À³¸Ó¥i¥H³Q²M·¡§e²{¡A¦Ó¨äÃa³B¬O³B²z®É¶¡¬ù»Ý¤T¤Ñ¡A¦]¦¹¥Ø«e¥u¹B¥Î¦b§Z¤lªº·¥Åé¤Á¤ù9¡C ¡@¡@¤Á¤ù¹LªºFL¾A¦X§Ná¶Ü¡H ¥Ø«e¨Ã¤£«Øij±N¤Á¤ù¹LªºFL§Ná¡B¦]¬°§Y¨Ï¨Ï¥Î§ï¨}¹Lªº§Ná¤èªk10¡B¨Ï¥Î§Ná«O¦s²Ä¤T¤Ñ¤Á¤ù¹LªºFL¨ä¦¨¥\²v¨Ã¤£°ª11,12¡C ¡@¡@»~§P²v¡G®Ú¾ÚESHRE PGD ¹Î¶¤¦b2002¦~ªº³ø¾É¡AFL´Ó¤J«e°ò¦]¶EÂ_¨ä»~§P²v¬ù¬° 2%(8/451)¡A¨ä¤¤¤¨Ò¨Ï¥ÎPCR¡A»~§P²v¬ù¬° 3%(5/145)¡F ¤T¨Ò¨Ï¥ÎFISH¡A»~§P²v¬ù¬° 1%(3/305) 13¡C ¡@¡@Ãh¥¥ªºµ²ªG¡G®Ú¾Ú°ê»ÚPGD¤u§@¤p²Õ2001¦~ªº³ø¾É¡A±µ¨üFL´Ó¤J«e°ò¦]¶EÂ_ªº¸ÕºÞÀ¦¨à¶g´Á¨äÃh¥¥²v»P¨S±µ¨ü°ò¦]¶EÂ_ªº¶g´Á¬Û·í14¡CStrom µ¥¤H¤ñ¸ûÅã·Lª`®g¤¤±µ¨üPGDªº·s¥Í¨à¤]µo²{µL½×¦bÃh¥¥¹Lµ{¡B¥X¥ÍÅ髩Ψ䥦¤è±¤]»P¤@¯ëÀ¦¨àµL²§15¡C ¡@¡@FL´Ó¤J«e°ò¦]¶EÂ_ªº¾AÀ³¯g¡G³æ°ò¦]¿ò¶Ç©Ê¯e¯f(monogenic disease)¦p£] ®ü¬v©Ê³h¦å¡]£] -thalassemia¡^¡BÅn¸~ÅÖºû¯fÅÜ¡]cystic fibrosis¡^¡B¯Ü®zX ¬V¦âÅé¯gÔ¸s¡]fragile X Syndrome¡^µ¥¡A©ÊÁp¿ò¶Ç¯e¯f¦pX-linked mental retardation¡A¬V¦âÅ鲧¦ì²§±`¦pReciprocal and Robertsonian translocation¡A«D¿¼Æ¬V¦âÅ骺¿zÀË(PGD for aneuploidy screening¡APGD-AS)¡C ¨ä¤¤PGD-AS¥i»¡¬O¥Ø«e¨Ï¥Î³Ì¬°´¶¹MªºPGD¡C¤@¯ë»¡¨Ó¹³°ªÄÖ°ü¤k¡A¦³²ßºD©Ê¬y²£¯f¥v¡A¦h¦¸¸ÕºÞÀ¦¨à¥¢±Ñµ¥µ¥³£¥i¾A¥Î¡A¥Ø«e¥«±¤W¦³²{½æªº±´¤l¡A±`°µªº¬V¦âÅ鬰13¡A15¡A16¡A17¡A18¡A21¡A22¡AX©MY¦@¤EÓ¡C¥Ñ©ó¦³Æ^®r¤l(Mosaicism)ªº°ÝÃD¡A¦]¦¹PGD-ASªº»~§P²v¬ù¬°6-7%16¡C
¡@¡@µ²½× ¡@¡@¥Ñ©ó§Þ³N¤W¤´¦³¨ä¨î¡A¥þ±ªº¸ÕºÞÀ¦¨àªvÀø¤W¨Ï¥ÎFL´Ó¤J«e°ò¦]¶EÂ_¥Ø«e©|µLªk¬I¦æ¡C¤£¹L¹ï¬Y¨Ç¯S©wªº±Ú¸s¡A¦¹§Þ³N±N¨Ï§Ú̦³§ó¦nªºFL¿ï¾Ü, ¨Ã¨Ï§Ú̯à´î¤ÖFLªº´Ó¤J¼Æ¥Ø¨Ã¶i¦Ó°§C¦hML§³®W¡C §Æ±æÀHµÛ¤£Â_¶i¨Bªº¹êÅç«Ç§Þ³N¡A§Ú̱N¥i´Ó¤J§ó¤ÖªºFL¦Ó«o¤£·|Ä묹±¼À³¦³ªºÃh¥¥²v¡C
Reference
-
Handyside A, Kontogianni E, Hardy K, Winston R. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature 1990; 344: 768¡V70.
-
Colls P, Chen S, Fischer J, et al. Preimplantation genetic diagnosis (PGD) reduces pregnancy loss in patients with previous recurrent miscarriages (RM). Program and abstracts from the American Society for Reproductive Medicine 60th Annual Meeting; October 16-20, 2004; Philadelphia, Pennsylvania. Abstract O69.
-
Werlin LB, Rodi I , DeCherney A, et al. Preimplantation genetic diagnosis (PGD) as a beneficial tool in women with recurrent pregnancy loss (RPL) and advanced maternal age (AMA). Program and abstracts from the American Society for Reproductive Medicine 60th Annual Meeting; October 16-20, 2004; Philadelphia, Pennsylvania. Abstract P-299
-
Turkaspa I, Cieslak ,J Morris R, et al. Preimplantation genetic diagnosis (PGD) for aneuploidy significantly improves ART and pregnancy outcome I Turkaspa et al. Program and abstracts from the American Society for Reproductive Medicine 60th Annual Meeting; October 16-20, 2004; Philadelphia, Pennsylvania. Abstract O72.
-
Stevens J, Wale P, Surrey ES, et al. Is aneuploidy screening for patients aged 35 or over beneficial? Program and abstracts from the American Society for Reproductive Medicine 60th Annual Meeting; October 16-20, 2004; Philadelphia, Pennsylvania. Abstract
-
Oter M, Sandalinas M, Colls P, et al. PGD of aneuploidy to reduce multiple gestations and maintain high pregnancy rates in women 35 and older. Program and abstracts from the American Society for Reproductive Medicine 60th Annual Meeting; October 16-20, 2004; Philadelphia, Pennsylvania. Abstract O75.
-
Boada M, Carrera M, De la Iglesia C, Sandalinas M, Barri PN, Veiga A. Successful use of a laser for human embryo biopsy in preimplantation genetic diagnosis: report of two cases.J Assist Reprod Genet 1998; 15: 302¡V07.
-
Wilton L, Voullaire L, Sargeant P, Williamson R, McBain J Preimplantation aneuploidy screening using comparative genomic hybridization or fluorescence in situ hybridization of embryos from patients with recurrent implantation failure
Fertil.Steril 2003 80, 4, 860-868)
-
Wells D, Escudero T, Levy B, Hirschhorn K, Delhanty J, Munn Á S. First clinical application of comparative genomic hybridisation and polar body testing for preimplantation genetic diagnosis of aneuploidy.Fertil Steril 2002; 78: 543¡V49.
-
Jericho H, Wilton L, Gook DA et al. 2003 A modified cryopreservation method increases the survival of human biopsied cleavage stage embryos. Human Reproduction 18, 568¡V571.
-
Joris H, Van den Abbeel, De Vos A et al. 1999 Reduced survival after human embryo biopsy and subsequent cryopreservation. Human Reproduction 14, 2833¡V2837.
-
Magli MC, Gianaroli L, Fortini D et al. 1999 Impact of blastomere biopsy and cryopreservation techniques on human embryo viability. Human Reproduction 14, 770¡V773.
-
ESHRE PGD Consortium Steering Committee. ESHRE Preimplantation Genetic Diagnosis Consortium: data collection III (May 2001). Hum Reprod 2002; 17: 233¡V46.
-
Anon. Report of the 11th annual meeting of International Working Group on Preimplantation Genetics: preimplantation genetic diagnosis¡Xexperience of 3000 clinical cycles. Reprod BioMed Online 2001; 3: 49¡V53.
-
Strom C, Levin R, Strom S, Masciangelo C, Kuliev A, Verlinsky Y. Neonatal outcome of preimplantation genetic diagnosis by polar body removal: the first 109 infants. Pediatrics 2000; 106: 650¡V53.
-
Munn Á S, Sandalinas M, Escudero T, Marquez C, Cohen J. Chromosome mosaicism in cleavage-stage human embryos: evidence of a maternal age effect. Repr BioMed Online 2003; 4: 223¡V32.
|